CRNX NASDAQ
Crinetics Pharmaceuticals, Inc.
1W: +0.2%
1M: +1.7%
3M: +146.1%
YTD: +81.8%
1Y: +177.2%
3Y: +394.2%
5Y: +289.3%
$84.95
Last traded 2026-08-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-02-28
Earliest Filing
2022-02-28
Latest Filing
partner: 1
Counterparties (Filed by CRNX)
1 relationshipsCompanies named in CRNX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Sanwa Kagaku Kenkyusho Co., Ltd. | — | partner | Entered into a licensing agreement for Sanwa to exclusively develop and commercialize paltusotine in Japan. | 2022-02-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-01 | Termination of Agreement; Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Dire | Acquisition | View |
| 2026-08-28 | Shareholder Vote; Exhibits | View | |
| 2026-08-19 | Other Events | View | |
| 2026-08-14 | Other Events | View | |
| 2026-08-03 | Earnings Release; Exhibits | View | |
| 2026-07-10 | Material Agreement; Officer/Director Change | Agreement | View |
| 2026-07-06 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-22 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-10 | Officer/Director Change; Exhibits | View | |
| 2026-03-23 | Officer/Director Change | View | |
| 2026-03-03 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-26 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-07 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-12-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-26 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR